Ms Anne O'Connor:

The recommendation was a review of the open disclosure policy. We have committed to doing our interim review by quarter 2, for which we are still on target. That is not just about changing the language in the policy. There is a significant amount of consultation with patients who are involved in that. That process is under way. We are awaiting feedback from patient groups on some of those elements. We are on target and that is part of the implementation plan. The date has always been quarter 2 of 2019.